These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26905044)

  • 1. "Engage" Therapy: Behavioral Activation and Improvement of Late-Life Major Depression.
    Alexopoulos GS; Raue PJ; Gunning F; Kiosses DN; Kanellopoulos D; Pollari C; Banerjee S; Arean PA
    Am J Geriatr Psychiatry; 2016 Apr; 24(4):320-6. PubMed ID: 26905044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Engage" therapy: Prediction of change of late-life major depression.
    Alexopoulos GS; O'Neil R; Banerjee S; Raue PJ; Victoria LW; Bress JN; Pollari C; Arean PA
    J Affect Disord; 2017 Oct; 221():192-197. PubMed ID: 28647669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reward learning impairment and avoidance and rumination responses at the end of Engage therapy of late-life depression.
    Victoria LW; Gunning FM; Bress JN; Jackson D; Alexopoulos GS
    Int J Geriatr Psychiatry; 2018 Jul; 33(7):948-955. PubMed ID: 29573471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement in Socially and Interpersonally Rewarding Activities as a Predictor of Outcome in "Engage" Behavioral Activation Therapy for Late-Life Depression.
    Solomonov N; Bress JN; Sirey JA; Gunning FM; Flückiger C; Raue PJ; Areán PA; Alexopoulos GS
    Am J Geriatr Psychiatry; 2019 Jun; 27(6):571-578. PubMed ID: 30797650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing engage with PST in late-life major depression: a preliminary report.
    Alexopoulos GS; Raue PJ; Kiosses DN; Seirup JK; Banerjee S; Arean PA
    Am J Geriatr Psychiatry; 2015 May; 23(5):506-13. PubMed ID: 25081818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting State Functional Connectivity and Outcomes of Psychotherapies for Late-Life Depression.
    Solomonov N; Victoria LW; Dunlop K; Respino M; Hoptman MJ; Zilcha-Mano S; Oberlin L; Liston C; Areán PA; Gunning FM; Alexopoulos GS
    Am J Geriatr Psychiatry; 2020 Aug; 28(8):859-868. PubMed ID: 32376080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The behavioral activation for depression scale-short form: development and validation.
    Manos RC; Kanter JW; Luo W
    Behav Ther; 2011 Dec; 42(4):726-39. PubMed ID: 22036000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of Frontostriatal Connectivity During Reward Processing Predicts Response to Psychotherapy in Major Depressive Disorder.
    Walsh E; Carl H; Eisenlohr-Moul T; Minkel J; Crowther A; Moore T; Gibbs D; Petty C; Bizzell J; Smoski MJ; Dichter GS
    Neuropsychopharmacology; 2017 Mar; 42(4):831-843. PubMed ID: 27585739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the streamlined psychotherapy "Engage" with problem-solving therapy in late-life major depression. A randomized clinical trial.
    Alexopoulos GS; Raue PJ; Banerjee S; Marino P; Renn BN; Solomonov N; Adeagbo A; Sirey JA; Hull TD; Kiosses DN; Mauer E; Areán PA
    Mol Psychiatry; 2021 Sep; 26(9):5180-5189. PubMed ID: 32612251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial factors associated with treatment outcomes in women with obesity and major depressive disorder who received behavioral activation for depression.
    Kern D; Busch A; Schneider KL; Miller SA; Appelhans BM; Waring ME; Whited MC; Pagoto S
    J Behav Med; 2019 Jun; 42(3):522-533. PubMed ID: 30467656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Predictions of Depression Symptoms Using the Activation and Avoidance Subscales of the Japanese Behavioral Activation for Depression Scale-Short Form.
    Shudo Y; Yamamoto T; Sakai M
    Psychol Rep; 2017 Feb; 120(1):130-140. PubMed ID: 27887002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Case Management versus Case Management with Problem-Solving Therapy in Low-Income, Disabled Elders with Major Depression: A Randomized Clinical Trial.
    Alexopoulos GS; Raue PJ; McCulloch C; Kanellopoulos D; Seirup JK; Sirey JA; Banerjee S; Kiosses DN; Areán PA
    Am J Geriatr Psychiatry; 2016 Jan; 24(1):50-59. PubMed ID: 25794636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential response of positive valence systems to psychotherapy for late-life depression: A pilot study.
    Bress JN; Gunning FM; Arader L; Areán PA; Alexopoulos GS
    J Affect Disord; 2023 Mar; 324():206-209. PubMed ID: 36586613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms of late-life depression: frequency and change during treatment.
    Nelson JC; Clary CM; Leon AC; Schneider LS
    Am J Geriatr Psychiatry; 2005 Jun; 13(6):520-6. PubMed ID: 15956272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study.
    Pilowsky DJ; Wickramaratne P; Talati A; Tang M; Hughes CW; Garber J; Malloy E; King C; Cerda G; Sood AB; Alpert JE; Trivedi MH; Fava M; Rush AJ; Wisniewski S; Weissman MM
    Am J Psychiatry; 2008 Sep; 165(9):1136-47. PubMed ID: 18558646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The German Version of the Behavioral Activation for Depression Scale (BADS): A Psychometric and Clinical Investigation.
    Teismann T; Ertle A; Furka N; Willutzki U; Hoyer J
    Clin Psychol Psychother; 2016 May; 23(3):217-25. PubMed ID: 25772711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.